S. Radin et al., Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release, J BIOMED MR, 57(2), 2001, pp. 313-320
Room temperature processed silica sol-gel (xerogel) was investigated as a n
ovel controlled release carrier of antibiotics (vancomycin). Xerogel charac
teristics, in vitro release properties, and bactericidal efficacy of the re
leased antibiotic were determined. The xerogel/vancomycin composite showed
a long-term sustained release (up to 6 weeks). In addition, bactericidal ef
ficacy of released vancomycin was retained. The kinetics of release and the
amount released were dose dependent. The initial, first-order release was
followed by a near-zero-order release. The time to transition from the firs
t- to zero-order release increased with vancomycin load (from 2 to 3 weeks
with load increase from 2.2 to 11.1 mg/g). Regardless of the load, about 70
% of the original vancomycin content was released by the transitional point
, and the cumulative release after 6 weeks of immersion was about 90%. This
study, combined with other reports documenting biocompatibility and contro
lled resorbability of the xerogel/drug, composite in vivo, suggests that si
lica xerogel is a promising controlled release material for the treatment o
f bone infections. (C) 2001 John Wiley & Sons, Inc.